New Alzheimer's drug candidate passes first safety hurdle in small trial
Disease control
Completed
This early-stage study tested the safety of a new drug called BMS-984923 in 51 healthy older adults and people with Alzheimer's disease. Participants received either the drug or a placebo to check for side effects and how the body processes the medication. The goal was to see if …
Phase: PHASE1 • Sponsor: Allyx Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC